CORT Latest Headlines

Shareholders Sue Corcept Therapeutics Over Cushing’s Syndrome Drug Claims

at www.tipranks.com (Thu, 2-Apr 5:40 AM)

Analysts Are Bullish on Top NA Stocks: Ottobock SE & Co. KGaA (OBCKF), Corcept Therapeutics (CORT)

at www.tipranks.com (Mon, 30-Mar 9:40 AM)

Wall Street Analysts Are Bullish on Top NA Picks

at www.tipranks.com (Mon, 30-Mar 7:32 AM)

Lifyorli’s FDA Approval Brings New Hope for Platinum-Resistant Ovarian Cancer – 35% Reduction in Death Risk Seen in ROSELLA Trial

Market Chameleon (Thu, 26-Mar 8:33 AM)

Deadline Approaches for Corcept Therapeutics Investors Amid Securities Class Action—What’s at Stake Before April 21, 2026?

Market Chameleon (Wed, 25-Mar 11:51 AM)

Corcept Faces Shareholder Lawsuit Deadline as FDA Setback Triggers Legal Scrutiny

Market Chameleon (Fri, 20-Mar 10:11 AM)

Corcept Therapeutics Hit By Shareholder Investigation As FDA Rejection Erases $3.6 Billion in Value

Market Chameleon (Thu, 22-Jan 11:19 AM)

Corcept’s Phase 3 ROSELLA Trial Shows Significant Survival Benefit for Relacorilant in Platinum-Resistant Ovarian Cancer

Market Chameleon (Thu, 22-Jan 8:45 AM)